A multivariate predictive modeling approach reveals a novel CSF peptide signature for both Alzheimer's Disease state classification and for predicting future disease progression
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A multivariate predictive modeling approach reveals a novel CSF peptide signature for both Alzheimer's Disease state classification and for predicting future disease progression
Authors
Keywords
Cerebrospinal fluid, Alzheimers disease, Medicine and health sciences, Biomarkers, Cognitive impairment, Research integrity, Health services administration and management, Neuronal differentiation
Journal
PLoS One
Volume 12, Issue 8, Pages e0182098
Publisher
Public Library of Science (PLoS)
Online
2017-08-04
DOI
10.1371/journal.pone.0182098
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- H-FABP: A new biomarker to differentiate between CT-positive and CT-negative patients with mild traumatic brain injury
- (2017) Linnéa Lagerstedt et al. PLoS One
- CSF Levels of Heart Fatty Acid Binding Protein are Altered During Early Phases of Alzheimer's Disease
- (2017) Davide Chiasserini et al. JOURNAL OF ALZHEIMERS DISEASE
- Development of new quantitative mass spectrometry and semi-automatic isofocusing methods for the determination of Apolipoprotein E typing
- (2016) Christophe Hirtz et al. CLINICA CHIMICA ACTA
- Regularization Paths for Generalized Linear Models via Coordinate Descent
- (2015) Jerome Friedman et al. Journal of Statistical Software
- A Subset of Cerebrospinal Fluid Proteins from a Multi-Analyte Panel Associated with Brain Atrophy, Disease Classification and Prediction in Alzheimer’s Disease
- (2015) Wasim Khan et al. PLoS One
- Multiplexing Determination of Small Cell Lung Cancer Biomarkers and Their Isovariants in Serum by Immunocapture LC-MS/MS
- (2014) Silje B. Torsetnes et al. ANALYTICAL CHEMISTRY
- Phosphorylated Tau-Aβ 42 Ratio as a Continuous Trait for Biomarker Discovery for Early-Stage Alzheimer’s Disease in Multiplex Immunoassay Panels of Cerebrospinal Fluid
- (2014) Oscar Harari et al. BIOLOGICAL PSYCHIATRY
- FABP3 Protein Promotes α-Synuclein Oligomerization Associated with 1-Methyl-1,2,3,6-tetrahydropiridine-induced Neurotoxicity
- (2014) Norifumi Shioda et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- An Integrated Workflow for Multiplex CSF Proteomics and Peptidomics—Identification of Candidate Cerebrospinal Fluid Biomarkers of Alzheimer’s Disease
- (2014) Mikko Hölttä et al. JOURNAL OF PROTEOME RESEARCH
- Identification of longitudinally dynamic biomarkers in Alzheimer’s disease cerebrospinal fluid by targeted proteomics
- (2014) Kristin R Wildsmith et al. Molecular Neurodegeneration
- Identification of Urinary Peptide Biomarkers Associated with Rheumatoid Arthritis
- (2014) Angelique Stalmach et al. PLoS One
- Improving CSF Biomarkers’ Performance for Predicting Progression from Mild Cognitive Impairment to Alzheimer’s Disease by Considering Different Confounding Factors: A Meta-Analysis
- (2014) Daniel Ferreira et al. Frontiers in Aging Neuroscience
- Genetic interaction analysis of Alzheimer's disease progression using phospho-tau as a covariate
- (2013) Ying Sun et al. Alzheimers & Dementia
- Heart-fatty acid-binding and tau proteins relate to brain injury severity and long-term outcome in subarachnoid haemorrhage patients
- (2013) E.R. Zanier et al. BRITISH JOURNAL OF ANAESTHESIA
- Cerebrospinal fluid biomarkers for pathological processes in Alzheimerʼs disease
- (2013) Christoffer Rosén et al. CURRENT OPINION IN PSYCHIATRY
- Heart-type fatty acid binding protein and vascular endothelial growth factor: cerebrospinal fluid biomarker candidates for Alzheimer’s disease
- (2013) Liang-Hao Guo et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- Targeted human cerebrospinal fluid proteomics for the validation of multiple Alzheimer's disease biomarker candidates
- (2013) Yong Seok Choi et al. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
- The Prognostic Significance of the Serum Biomarker Heart-Fatty Acidic Binding Protein in Comparison with S100b in Severe Traumatic Brain Injury
- (2013) Bernhard Walder et al. JOURNAL OF NEUROTRAUMA
- Evaluation of Plasma Proteomic Data for Alzheimer Disease State Classification and for the Prediction of Progression From Mild Cognitive Impairment to Alzheimer Disease
- (2012) Daniel A. Llano et al. ALZHEIMER DISEASE & ASSOCIATED DISORDERS
- Proteomic Changes in Cerebrospinal Fluid of Presymptomatic and Affected Persons Carrying Familial Alzheimer Disease Mutations
- (2012) John M. Ringman ARCHIVES OF NEUROLOGY
- Total ApoE and ApoE4 Isoform Assays in an Alzheimer's Disease Case-control Study by Targeted Mass Spectrometry (n= 669): A Pilot Assay for Methionine-containing Proteotypic Peptides
- (2012) Romain Simon et al. MOLECULAR & CELLULAR PROTEOMICS
- Addressing the Challenge of Defining Valid Proteomic Biomarkers and Classifiers
- (2011) Mohammed Dakna et al. BMC BIOINFORMATICS
- Identification of a novel biomarker candidate, a 4.8-kDa peptide fragment from a neurosecretory protein VGF precursor, by proteomic analysis of cerebrospinal fluid from children with acute encephalopathy using SELDI-TOF-MS
- (2011) Takeshi Asano et al. BMC Neurology
- Discovery and Preclinical Validation of Salivary Transcriptomic and Proteomic Biomarkers for the Non-Invasive Detection of Breast Cancer
- (2011) Lei Zhang et al. PLoS One
- Multiplexed Immunoassay Panel Identifies Novel CSF Biomarkers for Alzheimer's Disease Diagnosis and Prognosis
- (2011) Rebecca Craig-Schapiro et al. PLoS One
- Peptide Fingerprinting of Alzheimer's Disease in Cerebrospinal Fluid: Identification and Prospective Evaluation of New Synaptic Biomarkers
- (2011) Holger Jahn et al. PLoS One
- Novel CSF biomarkers for Alzheimer’s disease and mild cognitive impairment
- (2010) William T. Hu et al. ACTA NEUROPATHOLOGICA
- Development of an Ultra-Rapid Diagnostic Method Based on Heart-Type Fatty Acid Binding Protein Levels in the CSF of CJD Patients
- (2010) Yuki Matsui et al. CELLULAR AND MOLECULAR NEUROBIOLOGY
- Distribution of VGF peptides in the human cortex and their selective changes in Parkinson’s and Alzheimer’s diseases
- (2010) Cristina Cocco et al. JOURNAL OF ANATOMY
- Secretome proteomics for discovery of cancer biomarkers
- (2010) Manousos Makridakis et al. Journal of Proteomics
- Plasma Membrane Proteomics and Its Application in Clinical Cancer Biomarker Discovery
- (2010) Rikke Leth-Larsen et al. MOLECULAR & CELLULAR PROTEOMICS
- The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models
- (2010) NATURE BIOTECHNOLOGY
- Recommendations for Biomarker Identification and Qualification in Clinical Proteomics
- (2010) H. Mischak et al. Science Translational Medicine
- Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects
- (2009) Leslie M. Shaw et al. ANNALS OF NEUROLOGY
- Proteomics-derived cerebrospinal fluid markers of autopsy-confirmed Alzheimer’s disease
- (2009) Alex E. Roher et al. BIOMARKERS
- Neuronal pentraxin receptor in cerebrospinal fluid as a potential biomarker for neurodegenerative diseases
- (2009) Guo Nan Yin et al. BRAIN RESEARCH
- Proteomic Analysis of Alzheimers Disease Cerebrospinal Fluid from Neuropathologically Diagnosed Subjects
- (2009) Chera Maarouf et al. Current Alzheimer Research
- Multi-site assessment of the precision and reproducibility of multiple reaction monitoring–based measurements of proteins in plasma
- (2009) Terri A Addona et al. NATURE BIOTECHNOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started